Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of CFTR-Modulator Treatment in Cystic Fibrosis Lung Disease Using Novel Structural and Functional MRI

NCT04391322 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT04391322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04391322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of CFTR-Modulator Treatment in Cystic Fibrosis Lung Disease Using Novel Structural and Functional MRI
Lead sponsor
The Hospital for Sick Children
Phase
Observational
Overall status
Active, not recruiting
Start date
October 20, 2020
Completion date
June 30, 2026
Enrollment
86 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

group 1: healthy controls, group 2: stable cf, group 3: cf participants anticipated to receive cftr-modulator therapy, group 4: 4-8 yo cf participants starting triple combination modulator therapy